Suppr超能文献

抗淋巴因子抗体。II. 生物活性的特异性。

Anti-lymphokine antibody. II. Specificity of biological activity.

作者信息

Kuratsuji T, Yoshida T, Cohen S

出版信息

J Immunol. 1976 Nov;117(5 Pt.2):1985-91.

PMID:792334
Abstract

The present study was designed to explore the range of biologic activity of an anti-lymphokine antiserum (ALKS). This preparation, which was produced by a two-stage immunization procedure, was used to prepare Sepharose bead immunoadsorbent columns. Columns made with ALKS, but not with anti-control antiserum, could specifically remove MIF activity, but not LT, MF, or NCF activity from activated lymphocyte culture supernatants. MIF but not LT, MF, or NCF could be recovered from the beads by acid extraction. These findings, taken in conjunction with the previously described capacity of ALKS to remove MCF and SRF activity from supernatants, demonstrated that ALKS although prepared against a lymphokine preparation with multiple activities, has restricted specificity. Thus far, its traget appear to be those mediators that affect macrophages either in vitro or in vivo. The capacity of ALKS to suppress delayed hypersensitivity reactions in the guinea pig is consistent with these observations, since the macrophage is the predominant infiltrating cell in those reactions.

摘要

本研究旨在探索抗淋巴因子抗血清(ALKS)的生物活性范围。这种通过两阶段免疫程序制备的制剂,被用于制备琼脂糖珠免疫吸附柱。用ALKS而非抗对照抗血清制成的柱子,能够特异性地从活化淋巴细胞培养上清液中去除MIF活性,但不能去除LT、MF或NCF活性。通过酸提取可从珠子中回收MIF,而LT、MF或NCF则不能。这些发现,结合之前所描述的ALKS从上清液中去除MCF和SRF活性的能力,表明ALKS尽管是针对具有多种活性的淋巴因子制剂制备的,但其特异性有限。到目前为止,其靶点似乎是那些在体外或体内影响巨噬细胞的介质。ALKS抑制豚鼠迟发型超敏反应的能力与这些观察结果一致,因为巨噬细胞是这些反应中主要的浸润细胞。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验